Delpor Revenue and Competitors

Location

$4.9M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Delpor's estimated annual revenue is currently $852.5k per year.(i)
  • Delpor's estimated revenue per employee is $77,500
  • Delpor's total funding is $4.9M.

Employee Data

  • Delpor has 11 Employees.(i)
  • Delpor grew their employee count by -39% last year.

Delpor's People

NameTitleEmail/Phone
1
CSOReveal Email/Phone
2
Chief Commercial Officer (CCO)Reveal Email/Phone
3
Senior R&D Engineering ManagerReveal Email/Phone
4
R&D EngineerReveal Email/Phone
5
President & CEOReveal Email/Phone
6
Research AssociateReveal Email/Phone
7
Research AssociateReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Delpor?

Delpor is a clinical stage life sciences company that utilizes innovative drug-delivery technologies in order to develop once-yearly therapies for chronic conditions. The Company’s lead product is a 6-12-month formulation of Risperidone (drug/device combination product) for the treatment of schizophrenia. Delpor is also pursuing 6-12 month formulations of other drugs targeting CNS conditions including Neuromuscular Diseases, Neurodegenerative Diseases, Addiction, and other disorders.

keywords:N/A

$4.9M

Total Funding

11

Number of Employees

$852.5k

Revenue (est)

-39%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Delpor News

2022-04-20 - Micro Chemotherapy Market Size, Scope And Forecast ...

... And Forecast | Amgen, Celgene, MagForce AG, Nanotherapeutics, Spectrum Pharmaceuticals, Ablynx, AMAG, CytImmune, Delpor, Nanospectra.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.4M1138%N/A
#2
N/A11N/AN/A
#3
$1M12-81%N/A
#4
$1M12N/AN/A
#5
$1M12-29%N/A